Allovir, Inc. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q2 2019 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Allovir, Inc. quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q2 2019 to Q1 2023.
- Allovir, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
Deferred Income Tax Expense (Benefit), Quarterly (USD)